ARCHIVES

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

This article is from The Cancer Letter archive.

Vol. 23 No. 11 | March 21, 1997

Download PDF Visit The Full Archive

Related Articles

NCI blocked groups from phase III Iressa studies.

April 30, 2004

ASCO Honors Eight With Special Awards

May 24, 2002

Switch T CD-Rom To Save PDQ $1 Mil. Over Five Years

September 14, 1990

DCE Board Approves concept For New Studies On Black, White Differences In Cancer Rates

July 13, 1984

QOL Of Young Survivors Equal To Other Children

February 25, 2005

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000